Trademark: 90027168
Word
ONCOVALENT THERAPEUTICS
Status Date
Monday, November 13, 2023
Filing Date
Monday, June 29, 2020
Published for Opposition
Tuesday, August 17, 2021
Abandoned Date
Monday, November 13, 2023
5 Pharmaceuticals and medicines for the prevention and treatment of cancer; pharmaceuticals and medicines for the identification and treatment of tumors; pharmaceuticals preparations in the form of capsules, tablets, and powders for the treatment of cancer; intravenous pharmaceuticals, namely, vials for intravenous administration sold filled with preparations for the treatment of cancer; biological preparations for the prevention and treatment of cancer; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in the for testing and treatment of cancer; medical diagnostic reagents; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations in the nature of drug delivery agents that facilitate administration of other pharmaceutical preparations into the human body for enhanced treatment of cancer
42 Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; testing, inspection, research, or development of pharmaceutical preparations for the prevention and treatment of cancer; research and development of pharmaceuticals and medicines for the identification and treatment of tumors; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the fields of pharmaceutical and biological preparations; development of new technology for others in the fields of pharmaceuticals, biotechnology, and medicine; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, and diagnostics; biological research and analysis; chemical research; medical research, namely, conducting clinical trials for others
Nov 13, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 13, 2023
Abandonment - No Use Statement Filed
Apr 26, 2023
Automatic Update Of Assignment Of Ownership
Apr 13, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 12, 2023
Automatic Update Of Assignment Of Ownership
Apr 12, 2023
Sou Extension 3 Granted
Apr 10, 2023
Sou Extension 3 Filed
Apr 10, 2023
Sou Teas Extension Received
Mar 22, 2023
Automatic Update Of Assignment Of Ownership
Oct 18, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 17, 2022
Sou Extension 2 Granted
Oct 6, 2022
Sou Extension 2 Filed
Oct 17, 2022
Case Assigned To Intent To Use Paralegal
Oct 6, 2022
Sou Teas Extension Received
Apr 13, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 11, 2022
Sou Extension 1 Granted
Apr 11, 2022
Sou Extension 1 Filed
Apr 11, 2022
Sou Teas Extension Received
Oct 12, 2021
Noa E-Mailed - Sou Required From Applicant
Aug 17, 2021
Official Gazette Publication Confirmation E-Mailed
Aug 17, 2021
Published For Opposition
Jul 28, 2021
Notification Of Notice Of Publication E-Mailed
Jul 13, 2021
Approved For Pub - Principal Register
Apr 9, 2021
Teas/Email Correspondence Entered
Apr 8, 2021
Correspondence Received In Law Office
Apr 8, 2021
Teas Response To Office Action Received
Oct 8, 2020
Notification Of Non-Final Action E-Mailed
Oct 8, 2020
Non-Final Action E-Mailed
Oct 8, 2020
Non-Final Action Written
Sep 29, 2020
Assigned To Examiner
Jul 27, 2020
New Application Office Supplied Data Entered
Jul 2, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
